Literature DB >> 32324177

Some drugs for COVID-19.

.   

Abstract

Entities:  

Keywords:  ACE inhibitors; ARBs; Actemra; Advil; HIV; Kaletra; Kevzara; Motrin; NSAIDs; Plaquenil; Tylenol; acetaminophen; adverse effects; angiotensin receptor blockers; antiretrovirals; azithromycin; chloroquine; coronavirus; corticosteroids; hydroxychloroquine; ibuprofen; lopinavir; oseltamivir; remdesivir; ribavirin; ritonavir; safety; sarilumab; tocilizumab

Mesh：

Substances：

Year:  2020        PMID： 32324177

Source DB:  PubMed          Journal:  Med Lett Drugs Ther        ISSN： 0025-732X            Impact factor:   1.909


× No keyword cloud information.
  4 in total

Review 1.  What the dental practitioner needs to know about pharmaco-therapeutic modalities of COVID-19 treatment: A review.

Authors:  Najla Dar-Odeh; Shadia Elsayed; Hamzah Babkair; Shaden Abu-Hammad; Nebras Althagafi; Rayan Bahabri; Yasmin Salah Eldeen; Wejdan Aljohani; Osama Abu-Hammad
Journal:  J Dent Sci       Date:  2020-11-19       Impact factor: 2.080

2.  Transcriptome network analyses in human coronavirus infections suggest a rational use of immunomodulatory drugs for COVID-19 therapy.

Authors:  Henry Sung-Ching Wong; Chin-Lin Guo; Gan-Hong Lin; Kang-Yun Lee; Yukinori Okada; Wei-Chiao Chang
Journal:  Genomics       Date:  2021-01-20       Impact factor: 4.310

3.  Effect of early oseltamivir on outpatients without hypoxia with suspected COVID-19.

Authors:  Satoru Chiba
Journal:  Wien Klin Wochenschr       Date:  2020-12-09       Impact factor: 1.704

4.  COVID-19 and Down syndrome.

Authors:  Michele Callea; Francisco Cammarata-Scalisi; Angela Galeotti; Alberto Villani; Diletta Valentini
Journal:  Acta Paediatr       Date:  2020-07-01       Impact factor: 4.056
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.